Caught late (after months or years), some damage may not fully recover
Bioessays (2019) 41:e1900046
What conditions does it treat
Peter de Keizer's pioneering research at Erasmus University Medical Center to its current status as a leading senolytic research tool, FOXO4-DRI demonstrates how precise molecular targeting can enable selective elimination of harmful cellular populations while preserving healthy tissue function
Proprietary blend 280 mg* of: Rosemary (Rosemarinus officinalis)(leaf), N-Acetyl Cysteine, Milk Thistle (seed), Superoxide Dismutase (bovine), Catalase, L-Glutamine, Alpha Lipoic Acid, Milk Thistle Extract (Silybum marianum)(seed), Turmeric (curcumin)(rhizome) Extract, Glutathione (reduced)
What are the negative effects of BPC-157